Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trials.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2011 AND VI 50 AND IP 4
Results: 7
1
2
The pharmacokinetics of methanol in the presence of ethanol: a case study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
3
Pharmacokinetic Interaction of Vicriviroc with Other Antiretroviral Agents.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 4, p. 267, doi. 10.2165/11584560-000000000-00000
- Publication type:
- Article
4
Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 4, p. 253, doi. 10.2165/11584350-000000000-00000
- Publication type:
- Article
5
The Pharmacokinetics of Methanol in the Presence of Ethanol.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 4, p. 245, doi. 10.2165/11584250-000000000-00000
- Publication type:
- Article
6
Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 4, p. 229, doi. 10.2165/11584570-000000000-00000
- Publication type:
- Article
7
Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 4, p. 215, doi. 10.2165/11584340-000000000-00000
- Publication type:
- Article